Kidney Cancer

Improving diagnosis and treatment of kidney cancer using clinical imaging techniques.

About 90% of kidney cancers are classified as renal cell carcinomas. When diagnosed late, this type of cancer has a poor prognosis; however some patients end up having surgery to remove kidney cancers that are later found to be benign. These patients are often elderly, and this procedure can greatly impact on their quality of life and place additional burden on the remaining kidney.

To help determine the type of kidney cancer prior to surgery, a team of researchers at TRI are investigating whether clinical imaging can be used to diagnose the type of tumour, so clinicians can prescribe the most effective treatment for each patient before surgery takes place.The team has also started a clinically integrated biobank which stores cancer tissue, and genomic information to provide patients with the most personalised care possible.

This project is a collaboration between renal surgeons, scientists, radiologists and pathologists at the Princess Alexandra Hospital (PAH), the imaging research team from the Translational Research Institute (TRI) and the Centre for Kidney Disease Research (CKDR) from The University of Queensland. Find out more.


Related News

Key Researchers
Carolyn Mountford
Glenda Gobe
Sharon Del Vecchio
Simon Wood
Show More ...
Kidney Research at TRI Gains Momentum Translational kidney research at TRI is gaining momentum after receiving a $648,000 Project Grant from the National Health and Medical Research Council (NHRMC),...Read more